`Case 2:13-cv-00391-ES-JAD Document 203-3 Filed 01/19/16 Page 1 of 2 PagelD: 2485
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEWJERSEY
`
`JAZZ PHARMACEUTICALS, INC.,
`
`. Document Filed Electttmically
`
`Plaintiff,
`
`v.
`
`AMNBAL PHARMACEUTICALS, LLC,
`
`Defendant.
`
`x
`
`Civil Action No. 13-39i-Es-JAD
`
`District Judge Esther Salas
`Magistrate Judge Joseph A. Dickson
`
`ORDER TO SEAL CERTAIN MATERIALS PURSUANT TO L. CIV. R. 5.3
`
`THIS MATTER having been brought before the Court: on Defendant Amneal
`
`Pharmaceuticals, LLC's Motion to Seal Certain Materials Pursuant to L. Civ .. R 5.3; and the
`
`Court: having considered the submission of the parties in connection with tht motion; and the
`
`Court: having considered the factors contained in L. Civ. R. 5.3(c}(2), the Court makes the
`
`following findings of fact and conclusions of law:
`
`1. Amneal Pharmaceuticals, LLC's January 19, 2016 letter v and exhibits to the
`
`Honorable JosephA, Dickson, U.S.M.J. {hereinafter the "Confidential Materials")
`
`contains confidential, technical, and business information that has been desigJ1attd as
`
`"HIGHLY CONFIDENTIAL-SUBJECT TO DISCOVERY CONFIDENTIALITY
`
`ORDER" by one or more of Plaintiff Jazz Pharmaceuticals, Inc, and Defendants
`
`Amneal Pharmaceuticals, LLC, Wockhardt Bio AGt and/or Par Pharmaceutical, Inc~
`
`(collectively the 4'Parties") under the Discovery Con:fic.ientiality Order entered in this
`
`case (D.l. 73).
`
`4:>71665 _i .docx
`
`. '
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 236 Filed 03/18/16 Page 2 of 2 PageID: 4590
`Case 2:13-cv-00391-ES-JAD Document 203-3 Filed 01/19/16 Page 2 of 2 PagelD: 2486
`
`2. The Parties have a legitimate interest in protecting the confidentiality of their trade
`
`secrets and other confidential research, development, development. commercial, and
`
`technical information.
`
`3. Public disclosure of 1his information would cause the Parties significant harm because
`
`public disclosure of trade secrets and other confidential research,, develdpinent,
`
`commercial, and technical information would provide the public insight into 1he
`
`business and operations of the Parties, their processes in consideriag and developing
`
`proprietary technology, and would give competitors an unfair advantage.
`
`4. Amneal Pharmaceuticals, LLC's requested sealing is the least restrictive alternative
`
`because it includes only the Confidential Materials, which contain confidential,
`
`technical, and business information that have been designated by the Parti~ as
`
`"HlGHL Y CONFIDENTIAL-SUBJECT TO DISCOVERY CONFIDENTIALITY
`J L•c.c.· c, fkt LQ.--\- IWI t( (tt.,.lf't! fht "t'W#rtf .fu ft-b/u,/7 /ff{ ,. rdo c.Jc,j 11trS(VI
`ORDEU " °'"""" o.. -~
`•'I of the (VIA:/.el't'o (..$
`j II tlf..'--Yf-fe>'I
`
`WHEREFORE, the Court having found that there are legitimate public and private
`
`interest which warrant the relief sought; for good cause shown:
`
`*~
`ITISONTHIS~~f ~cc~ ,2016
`
`ORDERED that the Confidential Materials that contain information that has been
`
`previously designated by
`
`the Parties as "HIGHLY CONFIDENTIAL~SUBJECT TO
`
`DISCOVERY CONFIDENTIALITY ORDER" are hereby SEALED. T~( ~; reJe>e-~r y 1~ of
`;41V111e41~ I /l'\/lc, Sc..b""'ts.S)ov1 /ECF#v, ;).cl.) / {"~II f(tnd.IA <;~a.ftdj tJ.,.J.. it 1 ~
`SO ORDERED:
`
`Dated; __ _ _ __ _ __ _
`Newark, New Jersey
`United States Magistrate Judge
`~ 6/l..DERE.0 ~+-, -fo ~ e~{cl\+ It-Vi ... ,- "'+ dot1.C! So o.!fi:sthl.,,, A-milta( st,, .. ti f"' hl1cl7 .P1 le C\
`I/I'(.'< r~HV"/ ks bte'7
`Vt~J011 6-f 1+1 //14/l~ S"bMIYS/dl )I\ whrc'1 0117 fk u,/l.f!r,{f;l'l...f-1...( J11,/!o1",.,,.,,..)(Vf
`(e cA.'4-Vfcc,/, T~ ~ S ""l>tf~~I~ ~ l,.,.t( he -h I ~c1 OI\ or hth- rt: Lf I I /I & 1 a~ tv1 G.ff ... c.l1tv\li'\-f
`f-o H'(cid:173)
`~uplc.."..c..:1-oM (. flvtt l ethf'.
`f
`4371665_1.docx
`"'7'-
`· -
`2
`
`